1,196 results on '"Maes, Louis"'
Search Results
2. 3-nitroimidazo[1,2-b]pyridazine as a novel scaffold for antiparasitics with sub-nanomolar anti-Giardia lamblia activity
3. Nucleoside analogues for the treatment of animal trypanosomiasis
4. Exploration of 6-methyl-7-(Hetero)Aryl-7-Deazapurine ribonucleosides as antileishmanial agents
5. N6-modification of 7-Deazapurine nucleoside analogues as Anti-Trypanosoma cruzi and anti-Leishmania agents: Structure-activity relationship exploration and In vivo evaluation
6. Long-term hematopoietic stem cells as a parasite niche during treatment failure in visceral leishmaniasis
7. Impact of pulmonary African trypanosomes on the immunology and function of the lung
8. Synthesis and Anti-Trypanosoma cruzi Activity of 3-Cyanopyridine Derivatives
9. Long-term hematopoietic stem cells trigger quiescence in Leishmania parasites
10. Synthesis and Anti-Chagas Activity Profile of a Redox-Active Lead 3-Benzylmenadione Revealed by High-Content Imaging
11. 6-Methyl-7-deazapurine nucleoside analogues as broad-spectrum antikinetoplastid agents
12. Synthesis and evaluation of 3′-fluorinated 7-deazapurine nucleosides as antikinetoplastid agents
13. Synthesis and evaluation of a collection of purine-like C-nucleosides as antikinetoplastid agents
14. Heteroaryl ether analogues of an antileishmanial 7-substituted 2-nitroimidazooxazine lead afford attenuated hERG risk: In vitro and in vivo appraisal
15. Sand Fly Studies Predict Transmission Potential of Drug-resistant Leishmania
16. Impact of clinically acquired miltefosine resistance by Leishmania infantum on mouse and sand fly infection
17. Comparative evaluation of nucleic acid stabilizing reagents for RNA- and DNA-based Leishmania detection in blood as proxy for visceral burdens
18. C6–O-alkylated 7-deazainosine nucleoside analogues: Discovery of potent and selective anti-sleeping sickness agents
19. Lead Optimization of the 5-Phenylpyrazolopyrimidinone NPD-2975 toward Compounds with Improved Antitrypanosomal Efficacy
20. Open Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and Beyond.
21. The Challenges of Effective Leishmaniasis Treatment
22. High throughput estimates of Wolbachia, Zika and chikungunya infection in Aedes aegypti by near-infrared spectroscopy to improve arbovirus surveillance
23. Impaired development of a miltefosine-resistant Leishmania infantum strain in the sand fly vectors Phlebotomus perniciosus and Lutzomyia longipalpis
24. Alkynamide phthalazinones as a new class of TbrPDEB1 inhibitors (Part 2)
25. Characterization of the role of N-glycosylation sites in the respiratory syncytial virus fusion protein in virus replication, syncytium formation and antigenicity
26. Screening of a PDE-focused library identifies imidazoles with in vitro and in vivo antischistosomal activity
27. Amino acid based prodrugs of a fosmidomycin surrogate as antimalarial and antitubercular agents
28. Synthesis and antimicrobial activities of N6-hydroxyagelasine analogs and revision of the structure of ageloximes
29. Revisiting tubercidin against kinetoplastid parasites: Aromatic substitutions at position 7 improve activity and reduce toxicity
30. In Vivo Bioluminescence Imaging Reveals Differences in Leishmania infantum Parasite Killing Kinetics by Antileishmanial Reference Drugs.
31. Chemoselective Synthesis and Anti-Kinetoplastidal Properties of 2,6-Diaryl-4 H -tetrahydro-thiopyran-4-one S -Oxides: Their Interplay in a Cascade of Redox Reactions from Diarylideneacetones.
32. DNDI-6174 is a preclinical candidate for visceral leishmaniasis that targets the cytochrome bc 1
33. In Vitro Growth Inhibition Assays of Leishmania spp.
34. Optimization of the pharmacokinetic properties of potent anti-trypanosomal triazine derivatives
35. Evaluation of a Pan-Leishmania Spliced-Leader RNA Detection Method in Human Blood and Experimentally Infected Syrian Golden Hamsters
36. Novel triazine dimers with potent antitrypanosomal activity
37. In-vivo evaluation of apocynin for prevention of Helicobacter pylori -induced gastric carcinogenesis
38. Long-term hematopoietic stem cells trigger quiescence inLeishmaniaparasites
39. Discovery of 5-Phenylpyrazolopyrimidinone Analogs as Potent Antitrypanosomal Agents with In Vivo Efficacy
40. In vitro CYP-mediated drug metabolism in the zebrafish (embryo) using human reference compounds
41. Optimization and characterization of a murine lung infection model for the evaluation of novel therapeutics against Burkholderia cenocepacia
42. Comparative analysis of the internalization of the macrophage receptor sialoadhesin in human and mouse primary macrophages and cell lines
43. Monoclonal antibody binding to the macrophage-specific receptor sialoadhesin alters the phagocytic properties of human and mouse macrophages
44. A novel serine protease inhibitor as potential treatment for dry eye syndrome and ocular inflammation
45. Correction to: Preparation and Characterization of Nanostructured Lipid Carriers for Improved Topical Drug Delivery: Evaluation in Cutaneous Leishmaniasis and Vaginal Candidiasis Animal Models
46. Preparation and Characterization of Nanostructured Lipid Carriers for Improved Topical Drug Delivery: Evaluation in Cutaneous Leishmaniasis and Vaginal Candidiasis Animal Models
47. Evaluation of a pan-Leishmania SL RNA qPCR assay for parasite detection in laboratory-reared and field-collected sand flies and reservoir hosts
48. Phenotypic adaptations of Leishmania donovani to recurrent miltefosine exposure and impact on sand fly infection
49. Structural Optimization of BIPPO Analogs as Potent Antimalarials
50. To Target or Not to Target Schistosoma mansoni Cyclic Nucleotide Phosphodiesterase 4A?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.